Table 3. Correlation between pharmacokinetic parameters and PFS.
Characteristics | 2-years PFS (%) | p-value* | |
---|---|---|---|
Cmax plasma T20 | 0.628 | ||
High | 55 | ||
Low | 50 | ||
Cmax plasma T40 | 0.547 | ||
High | 54 | ||
Low | 55 | ||
Cmax plasma T60 | 0.342 | ||
High | 66 | ||
Low | 43 | ||
Cmax plasma T120 | 0.589 | ||
High | 63 | ||
Low | 63 | ||
Cmax perfusate T20 | 0.940 | ||
High | 58 | ||
Low | 50 | ||
Cmax perfusate T40 | 0.611 | ||
High | 58 | ||
Low | 26 | ||
Cmax perfusate T60 | 0.908 | ||
High | 56 | ||
Low | 50 | ||
Cmax peritoneum | 0.054 | ||
High | 70 | ||
Low | 35 |
PFS, progression-free survival.
*Calculated with log-rank test.